Article info

Download PDFPDF

Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis
  1. Tsutomu Takeuchi, Division of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan; tsutake{at}saitama-med.ac.jp
View Full Text

Citation

Takeuchi T, Tatsuki Y, Nogami Y, et al
Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis

Publication history

  • Accepted July 14, 2007
  • First published July 20, 2007.
Online issue publication 
January 11, 2008

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.